Skip to main content
Caplight Logo









Neocannbio

Neocannbio

Private
SeoulHealthcare & Life Scienceshttps://www.neocannbio.com/en/

Last Round

Series B

Sep 26, 2023

Est. Valuation

$40.6M

Total Funding Raised

$10.7M

Company Overview

Neocannbio is a biotechnology company that develops cannabinoid-based pharmaceutical raw materials and treatments for intractable diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cannabinoid pharmaceuticalsbiotech R&Ddrug discoveryAPIactive pharmaceutical ingredientcannabinoid therapeuticsmetabolic engineeringclinical researchpharma manufacturingGMP manufacturingcannabis biotechpharma licensingmedical cannabisdrug developmentbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neocannbio Comparables

Compare Neocannbio with similar companies based on industry and business-model similarity.

Neocannbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZYUS Life Sciences Corporation
78%
Avicanna Inc.
77%
InMed Pharmaceuticals
77%

Neocannbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 26, 2023
Series AJul 26, 2022

Neocannbio Investors

Notable investors and investment history

Neocannbio investors
InvestorRounds
KT&GSeries A
Bilanx InvestmentSeries B
QUAD Investment ManagementSeries B
HLB InvestmentSeries B
Hyundai Technology InvestmentSeries A
Medytox Venture InvestmentSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 26, 2023

    $7.4M round led by QUAD Investment Management and Bilanx Investment.

  • Jul 26, 2022

    $3.3M round with participation from KT&G and Hyundai Technology Investment.

Neocannbio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neocannbio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neocannbio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2021
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?